Brief: Appili Therapeutics Secures Contract For ATI-1701 Funding From The U.S. Air Force Academy
08/05/2023 13:03
May 8 (Reuters) - Appili Therapeutics Inc APLI.TO :
* APPILI THERAPEUTICS SECURES CONTRACT FOR ATI-1701 FUNDING
FROM
THE U.S. AIR FORCE ACADEMY
* APPILI THERAPEUTICS - INITIAL FUNDING, IN AMOUNT OF US$7.3
MILLION, WILL BE USED TO KICK-OFF ATI-1701 EARLY-STAGE
DEVELOPMENT AND REGULATORY ACTIVITIES
Source text for Eikon: ID:nBwRFngta
Further company coverage: APLI.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Appili Therapeutics
See all newsBrief: Appili Therapeutics Announces Closing Of Second Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Closes First Tranche Of Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Proposed Non-Brokered Private Placement
Brief: Appili Therapeutics Announces Formal Termination Of Arrangement Agreement With Aditxt
Brief: Appili Therapeutics Announces New Patents Granted For Commercial Stage Asset Likmez